- Report
- October 2019
- 125 Pages
Canada
From €4519EUR$4,750USD£3,870GBP
- Report
- March 2019
- 90 Pages
Asia Pacific
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2019
- 100 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Report
- February 2023
- 107 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- January 2022
- 200 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- April 2020
- 119 Pages
Global
From €3482EUR$3,660USD£2,982GBP
- Report
- February 2019
- 30 Pages
Global
From €9515EUR$10,000USD£8,147GBP
- Drug Pipelines
- February 2019
- 43 Pages
Global
From €9515EUR$10,000USD£8,147GBP
- Drug Pipelines
- February 2019
- 54 Pages
Global
From €9515EUR$10,000USD£8,147GBP
- Drug Pipelines
- February 2018
- 207 Pages
Global
From €20932EUR$22,000USD£17,923GBP
- Drug Pipelines
- February 2018
- 33 Pages
Global
From €9515EUR$10,000USD£8,147GBP
- Report
- May 2023
- 172 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- November 2022
- 120 Pages
Global
From €2379EUR$2,500USD£2,037GBP
- Report
- February 2021
- 90 Pages
Global
€20932EUR$22,000USD£17,923GBP
- Drug Pipelines
- June 2020
- 35 Pages
Global
From €1903EUR$2,000USD£1,629GBP
- Report
- August 2023
- 51 Pages
South Korea
From €571EUR$600USD£489GBP
- Report
- August 2023
- 51 Pages
India
From €571EUR$600USD£489GBP
- Report
- August 2023
- 51 Pages
Mexico
From €571EUR$600USD£489GBP
- Report
- August 2023
- 51 Pages
Australia
From €571EUR$600USD£489GBP
- Report
- August 2023
- 51 Pages
Japan
From €571EUR$600USD£489GBP
The Sodium Dependent Glucose Co Transporter 2 (SGLT2) market is a subset of the Endocrine and Metabolic Disorders Drugs market. SGLT2 inhibitors are a class of drugs used to treat type 2 diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin effectively. These drugs work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to reduce blood glucose levels and improve glycemic control.
The SGLT2 market is highly competitive, with several major pharmaceutical companies offering products. These include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen Pharmaceuticals, Merck, Novo Nordisk, and Sanofi. Each company offers a range of products, including both branded and generic versions. Show Less Read more